Crook J M, Bahadur Y A, Robertson S J, Perry G A, Esche B A
Department of Radiation Oncology, Ottawa Regional Cancer Centre, Ontario, Canada.
Cancer. 1997 Jan 1;79(1):81-9.
Sequential systematic biopsies after radiotherapy (RT) for prostate carcinoma were evaluated with respect to radiation effect, tumor differentiation, and prostate specific antigen (PSA) staining, and these histopathologic parameters were correlated with local outcome.
Since 1990, transrectal ultrasound-guided biopsies have been used to follow patients with localized prostate carcinoma after radical external RT at the General Hospital division of the Ottawa Regional Cancer Centre. Eighty-nine patients with residual tumor in 1 or more biopsies at 10-78 months of follow-up were selected for review. All patients had undergone biopsy on more than one occasion. The 198 biopsies were stained for PSA, high molecular weight keratin, and proliferative cell nuclear antigen (PCNA). Therapy effect was graded by nuclear and cytoplasmic changes.
Of these 89 selected patients, 25 progressed to local failure (LF), 38 had delayed tumor clearance, and 26 remained biopsy positive without local or biochemical progression. In the 24- and 36-month biopsies, RT effect correlated with mean nadir serum PSA (Grade 4-6 RT effect: 0.7 ng/mL; Grade 0-3 RT effect: 1.3 ng/mL [P = 0.01]) and with local outcome (Grade 0-2 RT effect: 55% LF; Grade 3-4 RT effect: 30% LF; and Grade 5-6 RT effect: 0% LF [P = 0.003]). Of tumors with minimal RT effect, 61% were PCNA positive, compared with 34% for moderate and 17% for marked RT effect (P < 0.001). Adjacent areas within biopsies showed varied RT effect in 27 patients, of whom 41% had local failure, compared with 18% of patients with uniform RT effect (P = 0.03). Gleason score was assigned only if RT effect was minimal (36 patients/59 biopsies); 74% had the same Gleason score (+/-1) as the original, whereas 23% were 2 points lower. Only 1 biopsy lost PSA staining completely and 10% stained faintly, whereas 34% stained moderately and 55% strongly.
PSA staining is apparently retained in residual tumor after RT, despite obvious RT effect. RT effect correlates with serum PSA nadir, PCNA staining, and local outcome. Varied RT effect is commonly observed in biopsies, and correlates with local failure. There is no convincing evidence for tumor dedifferentiation after RT.
对前列腺癌放疗(RT)后的序贯系统性活检进行了评估,涉及放射效应、肿瘤分化和前列腺特异性抗原(PSA)染色,并将这些组织病理学参数与局部预后相关联。
自1990年以来,渥太华地区癌症中心总医院分部对接受根治性体外放疗后的局限性前列腺癌患者采用经直肠超声引导活检进行随访。选择了89例在随访10 - 78个月时1次或多次活检有残留肿瘤的患者进行回顾。所有患者均接受过不止一次活检。对198份活检标本进行PSA、高分子量角蛋白和增殖细胞核抗原(PCNA)染色。通过细胞核和细胞质变化对治疗效果进行分级。
在这89例入选患者中,25例进展为局部失败(LF),38例肿瘤清除延迟,26例活检仍为阳性但无局部或生化进展。在24个月和36个月的活检中,放疗效果与平均最低血清PSA相关(放疗效果4 - 6级:0.7 ng/mL;放疗效果0 - 3级:1.3 ng/mL [P = 0.01]),也与局部预后相关(放疗效果0 - 2级:55% LF;放疗效果3 - 4级:30% LF;放疗效果5 - 6级:0% LF [P = 0.003])。放疗效果最小的肿瘤中,61%为PCNA阳性,而放疗效果中等的为34%,放疗效果显著的为17%(P < 0.001)。27例患者的活检相邻区域显示放疗效果各异,其中41%发生局部失败,而放疗效果均匀的患者中这一比例为18%(P = 0.03)。仅在放疗效果最小的情况下(36例患者/59份活检标本)进行Gleason评分;74%的评分与原评分相同(±1),而23%低2分。仅1份活检标本PSA染色完全消失,10%染色微弱,34%染色中等,55%染色强烈。
尽管放疗效果明显,但放疗后残留肿瘤中PSA染色明显保留。放疗效果与血清最低PSA、PCNA染色和局部预后相关。活检中常见放疗效果各异的情况,且与局部失败相关。没有令人信服的证据表明放疗后肿瘤去分化。